CYTOKINETICS INC
CYTK
92 insider filings · Latest: Oct 12, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 28, 2024 | Oct 28 8:12 PM | WENDELL WIERENGA | Proposed Sale | 4,452 | $52.25 | $232.6K | — | View → |
| Oct 15, 2024 | Oct 15 8:32 PM | FADY MALIK | Proposed Sale | 7,300 | $54.19 | $395.6K | — | View → |
| Oct 9, 2024 | Oct 9 8:08 PM | ROBERT BLUM | Proposed Sale | 5,000 | $55.61 | $278.1K | — | View → |
| Oct 1, 2024 | Oct 1 8:21 PM | FADY MALIK | Proposed Sale | 7,300 | $52.10 | $380.3K | — | View → |
| Sep 30, 2024 | Sep 30 8:06 PM | ROBERT BLUM | Proposed Sale | 5,000 | $52.14 | $260.7K | — | View → |
| Sep 17, 2024 | Sep 17 8:03 PM | FADY MALIK | Proposed Sale | 7,300 | $56.77 | $414.4K | — | View → |
| Sep 16, 2024 | Sep 16 8:29 PM | ROBERT BLUM | Proposed Sale | 5,000 | $55.99 | $280.0K | — | View → |
| Sep 9, 2024 | Sep 9 8:12 PM | B LYNNE PARSHALL | Proposed Sale | 5,000 | $54.92 | $274.6K | — | View → |
| Sep 3, 2024 | Sep 3 8:08 PM | ROBERT BLUM | Proposed Sale | 5,000 | $57.03 | $285.1K | — | View → |
| Sep 3, 2024 | Sep 3 8:07 PM | FADY MALIK | Proposed Sale | 7,384 | $57.01 | $421.0K | — | View → |
| Aug 26, 2024 | Aug 26 8:14 PM | B LYNNE PARSHALL | Proposed Sale | 5,000 | $57.26 | $286.3K | — | View → |
← Previous
Page 7 of 7
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 15, 2026 | Mar 17 8:11 PM | Robert I BlumDirector, President & CEO | Grant/Award | 113,529 | $60.06 | 111,864(D) | View → |
| Mar 15, 2026 | Mar 17 8:08 PM | Andrew CallosEVP, Chief Commercial Officer | Grant/Award | 31,145 | $60.06 | 29,480(D) | View → |
| Mar 15, 2026 | Mar 17 8:06 PM | Jeffrey HessekielChief Legal & Admin Officer | Grant/Award | 31,145 | $60.06 | 22,820(D) | View → |
| Mar 15, 2026 | Mar 17 8:05 PM | Sung LeeEVP, Chief Financial Officer | Grant/Award | 31,145 | $60.06 | 29,480(D) | View → |
| Mar 15, 2026 | Mar 17 8:03 PM | Fady Ibraham MalikEVP Research & Development | Grant/Award | 41,192 | $60.06 | 39,527(D) | View → |
| Mar 5, 2026 | Mar 5 9:27 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 26,000 | $39.13 | 69,000(D) | View → |
| Mar 2, 2026 | Mar 2 9:28 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 886 | $37.63 | 0(D) | View → |
| Feb 5, 2026 | Feb 6 1:17 AM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 15,000 | $23.26 | 84,000(D) | View → |
| Feb 2, 2026 | Feb 2 9:40 PM | Andrew CallosEVP, Chief Commercial Officer | Option Exercise | 886 | $37.63 | 886(D) | View → |
← Previous
Page 3 of 3